Affimed $AFMD Places Cancer Immunotherapy Candidate AFM11 on Clinical Hold after Patient Death httpow.lyzVdN30m9X51Âpic.twitter.comKwZM1bEasn
Affimed ($AFMD) Places #Cancer #Immunotherapy Candidate AFM11 on Clinical Hold after Patient Death: http://ow.ly/zVdN30m9X51 pic.twitter.com/KwZM1bEasn
More From BioPortfolio on "Affimed ($AFMD) Places #Cancer #Immunotherapy Candidate AFM11 on Clinical Hold after Patient Death: http://ow.ly/zVdN30m9X51 pic.twitter.com/KwZM1bEasn"